Latest Breaking News On - Psychopharmacologic drugs advisory - Page 1 : comparemela.com

An FDA advisory committee voted against recommending a psychedelic treatment for PTSD, citing insufficient data for what many described as a still-promising path forward.The Psychopharmacologic Drugs Advisory Committee met June 4 to discuss a new drug application for midomafetamine (MDMA) — submitted by Lykos Therapeutics, formerly MAPS Public Benefit Corporation. It was the first FDA

Stephanie viguersElizabeth joniakDavid millisByemma bascomMaryann amirshahiPublic benefit corporationUniversity of north carolinaMeeting of the psychopharmacologic drugs advisory committeeGeorgetown university school of medicineChapel hill injury prevention research centerNational capital poison centerPsychopharmacologic drugs advisory committeeLykos therapeuticsNorth carolinaChapel hillInjury prevention research center